# ALLI
> **NDA021887** · New Drug Application · Sponsor: HALEON US HOLDINGS · Approved 2007-02-07
## Drug
- **FDA Application Number:** NDA021887
- **Application type:** New Drug Application
- **Brand name:** ALLI
- **Generic name:** ORLISTAT
- **Active ingredients:** ORLISTAT
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** HALEON US HOLDINGS
- **Manufacturer:** Haleon US Holdings LLC
- **First approval:** 2007-02-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021887)
---
*AI Analytics · CC0 1.0*